{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["30(11)"],"submitter":["Martins Simoes P"],"pubmed_abstract":["Background<i>Staphylococcus haemolyticus</i> (SH) is an opportunistic pathogen associated with nosocomial infections, particularly bacteraemia in neonates. Epidemiological trends and genetic diversity of these infections worldwide are largely unknown.AimTo investigate an increase in SH vascular catheter-related bacteraemia in neonates and describe the molecular epidemiology in France between 2019 and 2023.MethodsWe analysed clinical and microbiological surveillance data from the French national surveillance network for central catheter-related (venous and umbilical) infections between 2019 and 2023. We also performed genomic and phylogenetic analyses of 496 strains isolated both inside (n = 383 from neonates, staff and environmental samples) and outside (n = 113 from adults) the neonatal i"],"journal":["Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11927072"],"repository":["biostudies-literature"],"pubmed_title":["Epidemiology of &lt;i&gt;Staphylococcus haemolyticus&lt;/i&gt; nosocomial bacteraemia in neonatal intensive care units, France, 2019 to 2023: predominance of the ST29 (CC3) multidrug-resistant lineage."],"pmcid":["PMC11927072"],"pubmed_authors":["Ranc AG","Vernet-Garnier V","Fascia P","Romano-Bertrand S","Leyssene D","Verhoeven P","Canouet S","Barreto C","Benet C","Lamoureux C","Menard C","Lecuyer H","Menard G","Donnio PY","Kolenda C","Vandenesch F","Dubois D","Bailly P","Cavalie L","Idri N","Vacher S","Bourgeois-Nicolaos N","Youenou B","Laurent F","Grattard F","Pailhories H","Deroin V","Fais T","Liberge M","Beauruelle C","Boileau P","Ledru S","Lemarie C","Dumont Y","van der Mee-Marquet N","Tristan A","Motte-Signoret E","Dupin C","Stordeur F","Maurin E","Martins Simoes P","Chagneau C","Gibert L","Grisi B","S. haemolyticus neonatal infections Study Group","Bertrand X","Cisse A","Lefflot S","Sauget M","Lawrence C","Le Glass E","Muggeo A","Labbe F","Mourlan C","Butin M","Dupieux-Chabert C","Berger-Carbonne A","Gaudichon A","Mezard I","Cheron M","Le Bars H","Plainvert C","Miquel C","Lecorche E","Lehours P","Laurens E","Bernard E","Tazi A","Lafeuille E","Le Bouedec S"],"additional_accession":[]},"is_claimable":false,"name":"Epidemiology of &lt;i&gt;Staphylococcus haemolyticus&lt;/i&gt; nosocomial bacteraemia in neonatal intensive care units, France, 2019 to 2023: predominance of the ST29 (CC3) multidrug-resistant lineage.","description":"Background<i>Staphylococcus haemolyticus</i> (SH) is an opportunistic pathogen associated with nosocomial infections, particularly bacteraemia in neonates. Epidemiological trends and genetic diversity of these infections worldwide are largely unknown.AimTo investigate an increase in SH vascular catheter-related bacteraemia in neonates and describe the molecular epidemiology in France between 2019 and 2023.MethodsWe analysed clinical and microbiological surveillance data from the French national surveillance network for central catheter-related (venous and umbilical) infections between 2019 and 2023. We also performed genomic and phylogenetic analyses of 496 strains isolated both inside (n = 383 from neonates, staff and environmental samples) and outside (n = 113 from adults) the neonatal i","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Mar","modification":"2026-06-01T06:04:43.683Z","creation":"2026-04-08T09:44:16.054Z"},"accession":"S-EPMC11927072","cross_references":{"pubmed":["40116031"],"doi":["10.2807/1560-7917.ES.2025.30.11.2400309"]}}